Iron Overload and Transient Elastography in Patients With Myelodysplastic Syndrome
NCT02262312 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2015-06-09
Summary
Patients with myelodysplastic syndrome (MDS) have an ineffective hemopoiesis and often suffer from anemia. This can lead to red blood cell transfusion dependency and iron overload. Iron overload can affect the liver and lead to liver fibrosis and worst case cirrhosis. Ferritin is usually used to monitor the iron overload. In this study MDS patients will have a transient elastography performed which measures the liver's stiffness. The purpose is to investigate whether liver stiffness measurements are coherent to ferritin levels.
Conditions
Interventions
- OTHER
-
Transient elastography
All patients will have a transient elastography performed as a measure of liver stiffness.
Sponsors & Collaborators
-
Zealand University Hospital
lead OTHER
Principal Investigators
-
Klas Raaschou-Jensen · Consultant at department of hematology
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2015-06-30
Countries
- Denmark
Study Locations
More Related Trials
-
Treatment of Iron Overload Requiring Chelation Therapy
NCT01927913 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload
NCT00564941 ·Status: COMPLETED ·Phase: PHASE4
-
Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients
NCT00117507 ·Status: COMPLETED ·Phase: PHASE4
-
Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome
NCT02943668 ·Status: TERMINATED ·Phase: PHASE2
-
Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms
NCT02823184 ·Status: COMPLETED
-
"Iron Overload and Endocrinological Diseases"
NCT06137079 ·Status: RECRUITING
-
A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer
NCT02905539 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome
NCT00095264 ·Status: COMPLETED ·Phase: PHASE2
-
This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.
NCT01250951 ·Status: COMPLETED ·Phase: PHASE4
-
Iron Substitution in Blood Donors
NCT01519830 ·Status: COMPLETED ·Phase: PHASE4
-
Hepcidin as a Predictor for the IVI Mediated Increase in Haemoglobin Levels
NCT04263571 ·Status: UNKNOWN
-
Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes
NCT00102245 ·Status: TERMINATED
-
High-Tc Susceptometer to Monitor Transfusional Iron Overload
NCT01241357 ·Status: COMPLETED
-
PICU Transfusion Study: Harmful Effects of Red Blood Cell Transfusions
NCT02087553 ·Status: COMPLETED
-
Ferric Carboxymaltose Methemoglobinemia Study
NCT06958822 ·Status: COMPLETED
-
Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients.
NCT06655662 ·Status: RECRUITING ·Phase: PHASE1
-
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
NCT00981370 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload
NCT01186419 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Deferiprone on Oxidative-Stress and Iron-Overload in Low Risk Transfusion-Dependent MDS Patients
NCT02477631 ·Status: COMPLETED ·Phase: PHASE2
-
Early and Low Dose Deferasirox (3.5 mg/kg FCT) to Suppress NTBI and LPI as Early Intervention to Prevent Tissue Iron Overload in Lower Risk MDS
NCT03920657 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
NCT02384122 ·Status: COMPLETED ·Phase: PHASE3
-
Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome (MDS)
NCT00057031 ·Status: UNKNOWN ·Phase: PHASE2
-
Mi-iron - Moderately Increased Iron - is Reducing Iron Overload Necessary?
NCT01631708 ·Status: COMPLETED ·Phase: NA
-
Combined Chelation Therapy in Patients With Transfusion Dependent Thalassemia and Iron Overload
NCT00901199 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Blood Transfusion on Endothelial Function
NCT02161042 ·Status: COMPLETED